Jim Cramer's hopeful on Abbott Labs after court case win
CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...
bovnews4d
Why Did Abbott Laboratories (ABT) Soar? Key Factors Explained
On Tuesday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.73 which represents a slight increase of $0.08 or 0.07% from the prior close of $117.65. The stock opened at ...
bovnews2d
Abbott Laboratories (ABT) Stock’s 0.05% Increase This Year: What’s the Story?
On Thursday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $115.3 which represents a decrease of $-1.50 or -1.28% from the prior close of $116.8. The stock opened at $117.49 and ...
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than ...
Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
Crain's Chicago Business10d
Abbott, Reckitt unit defeat claims in premature baby formula trial
The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
NBC New York9d
Jim Cramer's hopeful on Abbott Labs after court case win
CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months. Abbott was cleared Thursday night of ...